Cited by 124Treatment of Major DepressionAntioxidant Activity and Oxidative StressTryptophan and brain disorders

The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.

Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients

Gałecki, Piotr, Szemraj, Janusz, Bieńkiewicz, Małgorzata, Zboralski, Krzysztof, Gałecka, Elżbieta·2009·Human Psychopharmacology: Clinical and Experimental

DOI 10.1002/hup.1014

Open this paper in CoChat — free account

Abstract

Objective: There are numerous reports indicating disturbed equilibrium between oxidative processes and antioxidative defense in patients with depression. Moreover, depressive patients are characterized by the presence of elements of an inflammatory process, which is one of the sources of reactive oxygen species (ROS). In view of the above, it was decided to study both the effect of fluoxetine monotherapy and that of fluoxetine co‐administered with acetylsalicylic acid on lipid peroxidation and antioxidative defense in patients with the first depressive episode in their life. Method: Seventy seven patients with major depressive disorder (MDD), divided into two groups were included in the study. The first group, consisting of 52 patients, received fluoxetine 20 mg, and the second one, in addition to fluoxetine 20 mg, received 150 mg of acetylsalicylic acid. The activity of antioxidative enzymes, copper‐zinc superoxide dismutase (CuZnSOD, SOD1), catalase (CAT), glutathione peroxidase (GPSH‐x) and the concentration of malonyldialdehyde (MDA) was determined in erythrocytes, whereas the total antioxidant status (TAS) was determined in the plasma. All parameters were measured before and after three month therapy. Results: The obtained results indicate a significant decrease in the activity of SOD1, CAT and GSHP‐x, as well as in MDA concentration after the combined therapy. Also a significant TAS increase was observed after the combined therapy. The study demonstrated that combined therapy with fluoxetine and ASA is characterized by the same efficacy and clinical safety as fluoxetine monotherapy, resulting additionally in improvement of oxidative stress parameters in the patients treated for depression. Copyright © 2009 John Wiley & Sons, Ltd.

Integrity signals

Registry

Crossref · 10.1002/hup.1014

Cites

117 of 117 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Engin Üstün, Y. (n.d.) · DergiPark (Istanbul University) · Cited by 170,090
Yaşlı Kadınlarda Üreme Sağlığı
Kokanalı, D., & Üstün, Y. E. (2019) · DergiPark (Istanbul University) · Cited by 169,621
A rating scale for depression
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay
Benzie, I. F. F., & Strain, J. (1996) · Analytical Biochemistry · doi:10.1006/abio.1996.0292 · Cited by 23,027
Free radicals and antioxidants in normal physiological functions and human disease
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
The Role of Superoxide Anion in the Autoxidation of Epinephrine and a Simple Assay for Superoxide Dismutase
Misra, H. P., & Fridovich, I. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45228-9 · Cited by 9,097
A SPECTROPHOTOMETRIC METHOD FOR MEASURING THE BREAKDOWN OF HYDROGEN PEROXIDE BY CATALASE
Beers, R. F., & Sizer, I. W. (1952) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50881-x · Cited by 6,781
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07495-8 · Cited by 4,492
[2] Ferric reducing/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration
Benzie, I. F. F., & Strain, J. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)99005-5 · Cited by 3,940

Show all 116 references

Research works printed but not linked: 5

American Psychiatry Association, 1994, Diagnostic and statistical Manual of Mental Disorder
10.1016/j.resp22006.09.004 · DOI
Editorial, 1998, Fatty acid, cytokines, and major depression, Biol Psychiatry, 43, 313
10.1016/j.intimp2003.11.006 · DOI
10.1016/j. psychres.2006.04.013 · DOI

Sorted by citations

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors
Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness
Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
Self-citation
Role of oxidative stress in depression
Bhatt, S., Nagappa, A. N., & Patil, C. R. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.05.001 · Cited by 854
Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression
Leonard, B., & Maes, M. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.005 · Cited by 805
The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications
Moylan, S., Maes, M., Wray, N. R., & Berk, M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.33 · Cited by 529
A Meta-analysis of oxidative stress markers in depression
Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., & Jia, Y. (2015) · PLOS ONE · doi:10.1371/journal.pone.0138904 · Cited by 485
Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness
Berk, M., Dean, O. M., Drexhage, H. A., McNeil, J. J., Moylan, S., O'Neil, A. E., Davey, C. G., Sanna, L., & Maes, M. H. J. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-74 · Cited by 395
A review of peripheral biomarkers in major depression: The potential of inflammatory and oxidative stress biomarkers
Lopresti, A. L., Maker, G. L., Hood, S. D., & Drummond, P. D. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.09.017 · Cited by 371
New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors
Maes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325
Association of high-sensitivity C-reactive protein with de novo major depression
Pasco, J. A., Nicholson, G. C., Williams, L. J., Jacka, F. N., Henry, M. J., Kotowicz, M. A., Schneider, H. G., Leonard, B. E., & Berk, M. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.076430 · Cited by 321
The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression
Czarny, P., Wigner, P., Galecki, P., & Sliwinski, T. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.06.036 · Cited by 310
Self-citation
Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism
Smaga, I., Niedzielska, E., Gawlik, M., Moniczewski, A., Krzek, J., Przegaliński, E., Pera, J., & Filip, M. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.12.015 · Cited by 252
Chronic Stress and Oxidative Stress as Common Factors of the Pathogenesis of Depression and Alzheimer’s Disease: The Role of Antioxidants in Prevention and Treatment
Juszczyk, G., Mikulska, J., Kasperek, K., Pietrzak, D., Mrozek, W., & Herbet, M. (2021) · Antioxidants · doi:10.3390/antiox10091439 · Cited by 247
Antioxidants as potential therapeutics for neuropsychiatric disorders
Pandya, C. D., Howell, K. R., & Pillai, A. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.017 · Cited by 222
In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS), and autoimmune responses directed against O&NS‐damaged neoepitopes
Maes, M. H. J., Kubera, M., Leunis, J., Berk, M., Geffard, M., & Bosmans, E. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01908.x · Cited by 209
Peripheral Markers of Depression
Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197
The relevance of oxidative stress status in first episode and recurrent depression
Stefanescu, C., & Ciobica, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.05.022 · Cited by 179
The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder
Maurya, P. K., Noto, C. D. S., Rizzo, L. B., Rios, A. C., Nunes, S. O. V., Barbosa, D. S., Sethi, S., Zeni‐Graiff, M., Mansur, R. B., Maes, M. H. J., et al. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.08.016 · Cited by 174
Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients
Maes, M., Ruckoanich, P., Chang, Y. S., Mahanonda, N., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.008 · Cited by 169
The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors
Du, J., Zhu, M. F., Bao, H., Bai, L., Dong, Y., Xiao, C., Zhang, G. Y., Henter, I. D., Rudorfer, M. V., & Vitiello, B. (2014) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.876960 · Cited by 164
Effects of aquatic exercise on mental health, functional autonomy and oxidative stress in depressed elderly individuals: A randomized clinical trial
da Silva, L. A., Tortelli, L., Motta, J. V. D. S., Menguer, L., Mariano, S., Tasca, G. M., Silveira, G. D. B., Pinho, R. A., & Silveira, P. C. L. (2019) · Clinics · doi:10.6061/clinics/2019/e322 · Cited by 161
Therapeutic Strategies for Treatment of Inflammation-related Depression
Adžić, M., Brkic, Z., Mitić, M., Francija, E., Jovicic, M. J., Radulović, J., & Marić, N. P. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170828163048 · Cited by 162
Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: A 24-week follow-up study
Kotan, V. O., Sarandol, E., Kirhan, E., Ozkaya, G., & Kirli, S. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.03.021 · Cited by 149
Oxidative/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications
Anderson, G., & Maes, M. H. J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660738 · Cited by 148
The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments
Bortolato, B., F. Carvalho, A., K. Soczynska, J., I. Perini, G., & S. McIntyre, R. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150630171433 · Cited by 142
The Integrative Management of Treatment-Resistant Depression: A Comprehensive Review and Perspectives
Carvalho, A. F., Berk, M., Hyphantis, T. N., & McIntyre, R. S. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000357500 · Cited by 123
Natural products, micronutrients, and nutraceuticals for the treatment of depression: A short review
Nabavi, S. M., Daglia, M., Braidy, N., & Nabavi, S. F. (2015) · Nutritional Neuroscience · doi:10.1080/1028415x.2015.1103461 · Cited by 125
Anti‐inflammatory, antiapoptotic, and antioxidant activity of fluoxetine
Caiaffo, V., de Oliveira, B. D. R., de Sá, F. B., & Evêncio‐Neto, J. (2016) · Pharmacology Research & Perspectives · doi:10.1002/prp2.231 · Cited by 112
Harmine and Imipramine Promote Antioxidant Activities in Prefrontal Cortex and Hippocampus
Réus, G. Z., Stringari, R. B., de Souza, B., Petronilho, F., Dal-Pizzol, F., Hallak, J. E., Zuardi, A. W., Crippa, J. A., & Quevedo, J. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.5.13109 · Cited by 110
Cognitive Dysfunction in Depression – Pathophysiology and Novel Targets
Carvalho, A., Miskowiak, K., Hyphantis, T., Kohler, C., Alves, G., Bortolato, B., G. Sales, P., Machado-Vieira, R., Berk, M., & McIntyre, R. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203627 · Cited by 107
Putative neuroprotective agents in neuropsychiatric disorders
Dodd, S., Maes, M. H. J., Anderson, G., Dean, O. M., Moylan, S., & Berk, M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.11.007 · Cited by 105
Serum uric acid levels and the clinical characteristics of depression
Wen, S., Cheng, M., Wang, H., Yue, J., Wang, H., Li, G., Zheng, L., Zhong, Z., & Peng, F. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.10.010 · Cited by 104
Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches
Balmus, I. M., Ciobica, A., Antioch, I., Dobrin, R., & Timofte, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3975101 · Cited by 103
“Moreover, it has been also observed that GPX homologues could exert some antidepressant effects [136, 137], while Brown et al. [138] demonstrated that lipid peroxidation, DNA/RNA damage, and nitric oxide levels could be relevant markers in theMDD pathology.”
BackgroundInfluential
Antioxidant and Anti-Inflammatory Effects of Carotenoids in Mood Disorders: An Overview
Rasmus, P., & Kozłowska, E. (2023) · Antioxidants · doi:10.3390/antiox12030676 · Cited by 102
Effects of SSRIs on Peripheral Inflammatory Cytokines in Patients with Generalized Anxiety Disorder
Hou, R., Ye, G., Liu, Y., Chen, X., Pan, M., Zhu, F., Fu, J., Fu, T., Liu, Q., Gao, Z., et al. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.06.001 · Cited by 97
Role of Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways in the Etiology of Depression: Therapeutic Implications
Anderson, G., Berk, M., Dean, O. M., Moylan, S., & Maes, M. H. J. (2013) · CNS Drugs · doi:10.1007/s40263-013-0119-1 · Cited by 95
Protective Effects of Ascorbic Acid on Behavior and Oxidative Status of Restraint-Stressed Mice
Moretti, M., Budni, J., Santos, D. B., Antunes, A. A., Daufenbach, J. F., Manosso, L. M., Farina, M., & Rodrigues, A. L. S. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9892-4 · Cited by 92
Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia
Sowa-Kućma, M., Styczeń, K., Siwek, M., Misztak, P., Nowak, R. J., Dudek, D., RYBAKOWSKI, J. K., Nowak, G., & Maes, M. H. J. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9835-5 · Cited by 88
A single dose of S ‐ketamine induces long‐term antidepressant effects and decreases oxidative stress in adulthood rats following maternal deprivation
Réus, G. Z., Carlessi, A. S., Titus, S. E., Abelaira, H. M., Ignácio, Z. M., da Luz, J. R., Matias, B. I., Bruchchen, L., Florentino, D., Vieira, A. A. D. S., et al. (2015) · Developmental Neurobiology · doi:10.1002/dneu.22283 · Cited by 84
Fluoxetine affects antioxidant system and promotes apoptotic signaling in Wistar rat liver
Djordjevic, J., Djordjevic, A., Adzic, M., Elaković, I., Matić, G., & Radojcic, M. B. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.03.003 · Cited by 78
The role of inflammatory cytokines on the aetiopathogenesis of depression
Makhija, K., & Karunakaran, S. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413488220 · Cited by 81
An intricate relationship between pain and depression: clinical correlates, coactivation factors and therapeutic targets
Chopra, K., & Arora, V. K. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.855720 · Cited by 77
DNA Damage in Major Psychiatric Diseases
Raza, M. U., Tufan, T., Wang, Y., Hill, C. P., & Zhu, M. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9621-9 · Cited by 70
The molecular aspects of oxidative & nitrosative stress and the tryptophan catabolites pathway (TRYCATs) as potential causes of depression
Wigner, P., Czarny, P. L., Gałecki, P., Su, K., & Śliwiński, T. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.09.045 · Cited by 65
Self-citation
Guanosine prevents behavioral alterations in the forced swimming test and hippocampal oxidative damage induced by acute restraint stress
Bettio, L. E. B., Freitas, A. E., Neis, V. B., Santos, D. B., Ribeiro, C. M., da Rosa, P. B., Farina, M., & Rodrigues, A. L. S. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.10.002 · Cited by 59
Oxidative stress parameters and antioxidants in adults with unipolar or bipolar depression versus healthy controls: Systematic review and meta-analysis
Jiménez‐Fernández, S., Gurpegui, M., Rojas, D. G., Gutiérrez-Rojas, L., Carretero, M. D., & Correll, C. U. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.07.015 · Cited by 60
Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression
Maes, M. H. J. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9326-6 · Cited by 55
Role of MMP-2, MMP-7, MMP-9 and TIMP-2 in the development of recurrent depressive disorder
Bobińska, K., Szemraj, J., Czarny, P. L., & Gałecki, P. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.03.068 · Cited by 54
Self-citation
Malondialdehyde plasma concentration correlates with declarative and working memory in patients with recurrent depressive disorder
Talarowska, M. E., Gałecki, P., Maes, M. H. J., Gardner, A., Chamielec, M., Orzechowska, A., Bobińska, K., & Kowalczyk, E. (2011) · Molecular Biology Reports · doi:10.1007/s11033-011-1335-8 · Cited by 53
Self-citation
IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) than in major depression
Maes, M., Mihaylova, I., Kubera, M., Leunis, J.-C., Twisk, F. N. M., & Geffard, M. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9316-8 · Cited by 52
Evidence for protective effect of lipoic acid and desvenlafaxine on oxidative stress in a model depression in mice
Silva, M. C. C., de Sousa, C. N. S., Gomes, P. X. L., de Oliveira, G. V., de Araújo, F. Y. R., Ximenes, N. C., da Silva, J. C., Vasconcelos, G. S., Leal, L. K. A. M., Macêdo, D. S., et al. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.08.002 · Cited by 52
Possible involvement of the JAK/STAT signaling pathway in N-acetylcysteine-mediated antidepressant-like effects
Al-Samhari, M. M., Al-Rasheed, N. M., Al-Rejaie, S. S., Al‐Rasheed, N. M., Hasan, I. H., Mahmoud, A. M., & Dzimiri, N. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215619707 · Cited by 52
Oxidative stress in elderly population: A prevention screening study
Gorni, D., & Finco, A. (2020) · Aging Medicine · doi:10.1002/agm2.12121 · Cited by 53
Variation of genes involved in oxidative and nitrosative stresses in depression
Wigner, P., Czarny, P. L., Synowiec, E., Bijak, M., Białek, K. I., Talarowska, M. E., Gałecki, P., Szemraj, J., & Śliwiński, T. (2018) · European Psychiatry · doi:10.1016/j.eurpsy.2017.10.012 · Cited by 48
Self-citation
Are Non-steroidal Anti-Inflammatory Drugs Clinically Suitable for the Treatment of Symptoms in Depression-Associated Inflammation?
Baune, B. T. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_19 · Cited by 47
The antidepressant effect of melatonin and fluoxetine in diabetic rats is associated with a reduction of the oxidative stress in the prefrontal and hippocampal cortices
Rebai, R., Jasmin, L., & Boudah, A. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.07.013 · Cited by 48
Synergist effects of n-acetylcysteine and deferoxamine treatment on behavioral and oxidative parameters induced by chronic mild stress in rats
Arent, C. O., Réus, G. Z., Abelaira, H. M., Ribeiro, K. F., Steckert, A. V., Mina, F., Dal‐Pizzol, F., & Quevedo, J. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.07.024 · Cited by 45
Oxidative stress, anti-oxidants and the cross-sectional and longitudinal association with depressive symptoms: results from the CARDIA study
Black, C. N., Penninx, B. W. J. H., Bot, M., Odegaard, A., Gross, M., Matthews, K. A., & Jacobs, D. R. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.5 · Cited by 44
An immune gate of depression—Early neuroimmune development in the formation of the underlying depressive disorder
Kowalczyk, M., Szemraj, J., Bliźniewska, K., Maes, M., Berk, M., Su, K.-P., & Gałecki, P. (2019) · Pharmacological Reports · doi:10.1016/j.pharep.2019.05.022 · Cited by 38
Self-citation
Targeting the Inflammatory Pathway as a Therapeutic Tool for Major Depression
Noto, C. D. S., Rizzo, L. B., Mansur, R. B., McIntyre, R. S., Maes, M. H. J., & Brietzke, E. M. (2014) · NeuroImmunoModulation · doi:10.1159/000356549 · Cited by 39
Tianeptine exerts neuroprotective effects in the brain tissue of rats exposed to the chronic stress model
Della, F. P., Abelaira, H. M., Réus, G. Z., Antunes, A. R., dos Santos, M. A. B., Zappellini, G., Steckert, A. V., Vuolo, F. S., Galant, L. S., Dal‐Pizzol, F., et al. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.09.018 · Cited by 39
Oxidant/antioxidant imbalance is an inherent feature of depression
Talarowska, M. E., Szemraj, J., Berk, M., Maes, M. H. J., & Gałecki, P. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0454-5 · Cited by 37
Self-citation
Total Antioxidant Status Correlates with Cognitive Impairment in Patients with Recurrent Depressive Disorder
Talarowska, M. E., Gałecki, P., Maes, M. H. J., Bobińska, K., & Kowalczyk, E. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0788-z · Cited by 35
Self-citation
Lipid Peroxidation and Depressed Mood in Community-Dwelling Older Men and Women
Milaneschi, Y., Cesari, M., Simonsick, E. M., Vogelzangs, N., Kanaya, A. M., Yaffe, K. S., Patrignani, P., Metti, A. L., Kritchevsky, S. B., Pahor, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065406 · Cited by 35
Acute administration of Zn, Mg, and thiamine improves postpartum depression conditions in mice.
Nikseresht, S., Etebary, S., Karimian, M., Nabavizadeh, F., Zarrindast, M., & Sadeghipour, H. R. (2012) · PubMed · Cited by 33
Effects of transcranial photobiomodulation and methylene blue on biochemical and behavioral profiles in mice stress model
Meynaghizadeh-Zargar, R., Sadigh‐Eteghad, S., Mohaddes, G., Salehpour, F., & Rasta, S. H. (2019) · Lasers in Medical Science · doi:10.1007/s10103-019-02851-z · Cited by 30
DNA damage and repair in neuropsychiatric disorders. What do we know and what are the future perspectives?
Czarny, P. L., Białek, K. I., Ziółkowska, S., Strycharz, J., & Śliwiński, T. (2019) · Mutagenesis · doi:10.1093/mutage/gez035 · Cited by 32
Effects of venlafaxine on the expression level and methylation status of genes involved in oxidative stress in rats exposed to a chronic mild stress
Wigner, P., Synowiec, E., Czarny, P. L., Bijak, M., Jóźwiak, P., Szemraj, J., Gruca, P., Papp, M., & Śliwiński, T. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15231 · Cited by 32
Self-citation
Interactions of atenolol with alprazolam/escitalopram on anxiety, depression and oxidative stress
Shahzad, N., Ahmad, J., Khan, W., Alghamdi, S., Ain, M. R., Ibrahim, I. A. A., Akhtar, M., & Khanam, R. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.12.015 · Cited by 29
Antioxidant-Like Effects and Protective Action of Transcranial Magnetic Stimulation in Depression Caused by Olfactory Bulbectomy
Tasset, I., Drucker-Colı́n, R., Peña, J., Jimena, I., Montilla, P., Medina-Fernández, F. J., & Túnez, I. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0172-9 · Cited by 28
Somatic Drugs for Psychiatric Diseases: Aspirin or Simvastatin for Depression?
Rahola, J. G. (2012) · Current Neuropharmacology · doi:10.2174/157015912800604533 · Cited by 28
Redox proteomics and drug development
D’Alessandro, A., Rinalducci, S., & Zolla, L. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.01.001 · Cited by 27
S-allyl Cysteine, a Garlic Compound, Produces an Antidepressant-Like Effect and Exhibits Antioxidant Properties in Mice
Ruiz-Sánchez, E., Pedraza‐Chaverrí, J., Medina‐Campos, O. N., Maldonado, P. D., & Rojas, P. (2020) · Brain Sciences · doi:10.3390/brainsci10090592 · Cited by 27
Evaluation of the Therapeutic Effect of Curcumin-Conjugated Zinc Oxide Nanoparticles on Reserpine-Induced Depression in Wistar Rats
Fahmy, H. M., Aboalasaad, F. A., Mohamed, A. S., Elhusseiny, F. A., Khadrawy, Y. A., & Elmekawy, A. F. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-03849-z · Cited by 26
The enhanced serotonin (5-HT) synthesis and anti-oxidative roles of Trp oligopeptide in combating anxious depression C57BL/6 mice
Zhu, X., Sun‐Waterhouse, D., Tao, Q., Li, W., Shu, D., & Cui, C. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103859 · Cited by 27
Mechanism of synergistic action on behavior, oxidative stress and inflammation following co-treatment with ketamine and different antidepressant classes
Réus, G. Z., Matias, B. I., Maciel, A. L., Abelaira, H. M., Ignácio, Z. M., de Moura, A. B., Matos, D., Danielski, L. G., Petronilho, F. C., Carvalho, A. F., et al. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.04.021 · Cited by 21
Youth Depression Alleviation‐Augmentation with an anti‐inflammatory agent ( YoDA‐A ): protocol and rationale for a placebo‐controlled randomized trial of rosuvastatin and aspirin
Quinn, A. L., Dean, O. M., Davey, C. G., Kerr, M., Harrigan, S., Cotton, S., Chanen, A. M., Dodd, S., Ratheesh, A., Amminger, G. P., et al. (2015) · Early Intervention in Psychiatry · doi:10.1111/eip.12280 · Cited by 20
Weekend warrior exercise model for protection from chronic mild stress‑induced depression and ongoing cognitive impairment
Öztürk, Ç. Ç., Ataoğlu, S. N., Arvas, A., Tokol, H., Yaprak, H., Gürel, S., Levent, H. N., Akakın, D., Şahin, A., Çakır, B., et al. (2023) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2023-002 · Cited by 19
Forced Swimming-Induced Depressive-like Behavior and Anxiety Are Reduced by Chlorpheniramine via Suppression of Oxidative and Inflammatory Mediators and Activating the Nrf2-BDNF Signaling Pathway
Al-Amri, H. S., Mufti, R., Sabir, D. K., Abuderman, A., Dawood, A. F., ShamsEldeen, A. M., Haidara, M. A., Isenović, E. R., & El-Bidawy, M. H. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45080407 · Cited by 21
Pro-inflammatory Cytokines in Psychiatric Disorders in Children and Adolescents: A Review
Miłkowska, P., Popko, K., Demkow, U. A., & Wolańczyk, T. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2017_32 · Cited by 18
The gender difference of selective serotonin reuptake inhibitor, fluoxetine in adult rats with stress-induced gastric ulcer
Abdel-Sater, K. A., Abdel-Daiem, W. M., & Bakheet, M. S. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.04.019 · Cited by 18
Protective effect of nicotine on oxidative and cell damage in rats with depression induced by olfactory bulbectomy
Túnez, I., Drucker-Colı́n, R., Montilla, P., Peña, J., Jimena, I., Medina-Fernández, F. J., & Tasset, I. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.10.061 · Cited by 18
Working memory impairment as a common component in recurrent depressive disorder and certain somatic diseases.
Gałecki, P., Talarowska, M. E., Moczulski, D. K., Bobińska, K., Opuchlik, K., Gałecka, E., Florkowski, A., & Lewiñski, A. (2013) · PubMed · Cited by 17
Self-citation
Chlorpheniramine and escitalopram: Similar antidepressant and nitric oxide lowering roles in a mouse model of anxiety
Gammoh, O. S., Mayyas, F., & Elhajji, F. D. (2017) · Biomedical Reports · doi:10.3892/br.2017.901 · Cited by 16
Neither all anti-inflammatory drugs nor all doses are effective in accelerating the antidepressant-like effect of fluoxetine in an animal model of depression
Alboni, S., Benatti, C., Capone, G., Tascedda, F., & Brunello, N. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.04.063 · Cited by 16
THE PRESENCE OF PERIPHERAL INFLAMMATORY MARKERS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER, THE ASSOCIATED SYMPTOMS PROFILES AND THE ANTIDEPRESSANT EFFICACY OF CELECOXIB
ENĂTESCU, V. R. (2020) · FARMACIA · doi:10.31925/farmacia.2020.3.14 · Cited by 16
Resveratrol ameliorates depressive disorder through the NETRIN1-mediated extracellularï¿½signal-regulated kinase/cAMP signal transduction pathway
Wang, F., Wang, J., An, J., Yuan, G., Hao, X., & Zhang, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.8379 · Cited by 16
Chronic fluoxetine treatment increases NO bioavailability and calcium-sensitive potassium channels activation in rat mesenteric resistance arteries
Pereira, C. A., Ferreira, N. S., Mestriner, F., Antunes‐Rodrigues, J., Évora, P. R. B., Resstel, L. B. M., Carneiro, F. S., & Tostes, R. C. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.09.002 · Cited by 15
Psychological stress impairs ischemia-induced neovascularization: Protective effect of fluoxetine
Maingrette, F., Dussault, S., Dhahri, W., Desjarlais, M., Mathieu, R., Turgeon, J., Haddad, P., Groleau, J., Pérez, G., & Rivard, A. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.010 · Cited by 16
Ameliorative effects of oyster (Crassostrea hongkongensis) protein hydrolysate on age-induced cognitive impairment via restoring glia cell dysfunction and neuronal injured in zebrafish
Zhu, G., Zhang, C., Qin, X., Cao, W., Zheng, H., & Gao, J. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104607 · Cited by 13
Effects of Aspirin in Rats With Ouabain Intracerebral Treatment—Possible Involvement of Inflammatory Modulation?
Zhang, L., An, L.-T., Qiu, Y., Shan, X., Zhao, W.-L., Zhao, J., Li, L., Lang, B., & Wu, R. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00497 · Cited by 14
Are Mood and Anxiety Disorders Inflammatory Diseases?
Boorman, E., Romano, G. F., Russell, A., Mondelli, V., & Pariante, C. M. (2015) · Psychiatric Annals · doi:10.3928/00485713-20150501-06 · Cited by 13
Pro-Inflammatory Cytokines in Psychiatric Disorders in Children and Adolescents: A Review
Miłkowska, P., Popko, K., Demkow, U. A., & Wolańczyk, T. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2017_24 · Cited by 12
Protective effect of aspirin and gentisic acid, a plant-derived phenolic acid, on acrylamide-induced neurotoxicity by inhibiting apoptosis and autophagy
Hosseinzadeh, Y., Rahbardar, M. G., Mehri, S., Razavi, B. M., & Hosseinzadeh, H. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03498-6 · Cited by 11
Majör depresif bozukluk ve yaygın anksiyete bozukluğunda malondialdehid ve E vitamini düzeyleri / Altered levels of malondialdehyde and vitamin E in major depressive disorder and generalized anxiety disorder
Bal, N., Acar, Ş. T., Yazıcı, A. C., & Tamer, L. (2012) · Dusunen Adam The Journal of Psychiatry and Neurological Sciences · doi:10.5350/dajpn2012250302 · Cited by 11
Oxidative Stress in Depression
Gałecki, P. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_190 · Cited by 11
Self-citation
Once induced, it lasts for a long time: the structural and molecular signatures associated with depressive-like behavior after neonatal immune activation
Khantakova, J. N., Bondar, N. P., Antontseva, E. V., & Reshetnikov, V. V. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1066794 · Cited by 10
A red pomegranate fruit extract-based formula ameliorates anxiety/depression-like behaviors via enhancing serotonin (5-HT) synthesis in C57BL/6 male mice
Zhu, X., Sun‐Waterhouse, D., & Cui, C. (2021) · Food Science and Human Wellness · doi:10.1016/j.fshw.2021.02.020 · Cited by 10
Serum uric acid is not associated with major depressive disorder in European and South American populations: a meta-analysis and two-sample bidirectional Mendelian Randomization study
Chen, Z., Liang, S., Bai, Y., Lin, J., Li, M., Mo, Z., Xie, S., Huang, S., & Long, J. (2022) · European Journal of Clinical Nutrition · doi:10.1038/s41430-022-01165-8 · Cited by 9
Pharmacological and Nonpharmacological Interventions to Arrest Neuroprogression in Psychiatric Disorders
Boufidou, F., & Halaris, A. E. (2017) · Modern trends in psychiatry · doi:10.1159/000470814 · Cited by 9

Authors: Gałecki, P., Szemraj, J., Bieńkiewicz, M., Zboralski, K., & Gałecka, E.
Affiliations: Medical University of Lodz (PL)
Corresponding author: Gałecki, Piotr
ORCID: Gałecki, Piotr
Szemraj, Janusz
Venue: Human Psychopharmacology: Clinical and Experimental
Publisher: Wiley
Published: 2009-03-24
Volume: 24
Issue: 4
Pages: 277-286
ISSN: 0885-6222 (ISSN-L)
1099-1077
DOI: 10.1002/hup.1014
OpenAlex: W2097745840
Cited by: 124
References: 116
Citations by year: 2024: 5 · 2023: 6 · 2022: 8 · 2021: 6 · 2020: 7 · 2019: 7 · 2018: 6 · 2017: 11 · 2016: 6 · 2015: 16 · 2014: 7 · 2013: 8 · 2012: 16
FWCI: 7.43
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Human Psychopharmacology Clinical and Experimental (publishedVersion)
PubMed (publishedVersion)
Funders: Uniwersytet Łódzki
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords: major depressive disorder, fluoxetine, aspirin, oxidative stress, lipid peroxidation, antioxidant enzymes, superoxide dismutase, catalase, glutathione peroxidase, malondialdehyde, total antioxidant status, combination therapy, first-episode depression, erythrocytes
MeSH terms: Adult, Anti-Inflammatory Agents, Non-Steroidal, Antioxidants, Aspirin, Major Depressive Disorder, Drug Therapy, Combination, Fluoxetine, Humans, Psychiatric Status Rating Scales, Lipid Peroxidation, Oxidative Stress, Antidepressive Agents, Second-Generation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks